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Ovine scrapie is a fatal neurodegenerative disorder that may be
transmitted through exposure to infected uterine and placental
tissues. Susceptibility to scrapie is primarily controlled by polymor-
phisms in the prion protein (PrP) gene. Scrapie in the U.S. Suffolk
breed and in many breeds in Europe occurs in sheep homozygous
for glutamine (171QQ), but rarely in sheep heterozygous for
glutamine and arginine (171QR) or homozygous for arginine
(171RR) at codon 171 of the PrP gene. This study demonstrated that
accumulation of PrPSc in uterine-placental epithelial cells in the
placentome was determined by fetal PrP genotype and the preg-
nancy status of scrapie-infected ewes. PrPSc was detected in 171QQ
placentomes of infected ewes, but not in placentomes of infected
ewes pregnant with 171QR conceptuses or in the non-pregnant
uterus of infected ewes. The distribution of PrPSc plaques in
placentomes was temporally associated with stage of gestation.
There was a tendency toward increased size and number of
placentomal PrPSc plaques from the endometrial stalk (maternal
side) to chorionic plate (fetal side). These results indicate that
accumulation of PrPSc is eliminated or reduced to undetectable
levels in reproductive and placental tissues if infected ewes are not
pregnant or conceive conceptuses with a resistant PrP genotype.
Ovine scrapie is a fatal neurodegenerative disorder presum-ably caused by the aggregated proteinase K (PK) resistant
form of the sheep prion (PrPSc), which is derived from an
endogenous, PK-sensitive cellular precursor (PrPC) through
conformational alteration (1–6). This host protein is encoded by
a single copy gene (2) and expressed by many cell and tissue types
(7–10). In several species, individuals with certain coding mu-
tations in the prion gene are predisposed to prion disease (3, 11,
12). Susceptibility to scrapie infection in Suffolk sheep and
Suffolk crosses is determined primarily by codon 171 of the prion
gene (11, 13). Sheep homozygous for glutamine at codon 171
(171QQ) are susceptible to scrapie, whereas sheep heterozygous
for glutamine and arginine (171QR) or homozygous for arginine
(171RR) are usually resistant to scrapie (11, 13).
In sheep, PrPSc or scrapie infectivity is present primarily in
tissues of the central and peripheral nervous system, lymphore-
ticular system, and placenta (9, 14–21). Recent studies of
reproductive and placental tissues from scrapie-infected preg-
nant sheep demonstrated that PrPSc accumulates at the fetal–
maternal interface (the placentome) and proposed that scrapie
is not transmitted in utero, but may be transmitted from infected
dams to their scrapie susceptible lambs during the perinatal
period by exposure to infectious placental tissues (9). The ovine
placentome is a natural chimera consisting of interdigitating
uterine endometrial septae and placental chorionic villi (Fig. 1),
in which the uterine cells carry the maternal genotype and the
placental chorionic cells carry the fetal genotype. The unique
structures of the placentome provide an applicable model for the
study of the effect of prion genotype on scrapie transmission
between tissues with intimate physical contact within a natural
host for scrapie. The advantages of this model are that the
placentomal PrPSc in the infected ewes is abundant for detection
and PrP genotypes of the placentomal components can be
controlled by breeding.
This study determined the effects of pregnancy stage, fetal PrP
genotype, and pregnancy status on PrPSc accumulation at the
fetal–maternal interface of scrapie-infected ewes. This study
showed that accumulation of PrPSc in both uterine epithelial and
placental trophoblast cells is determined by PrP genotype of the
fetus and the pregnancy status of the infected ewe, and that the
pattern of PrPSc plaque distribution in placentomes is associated
with gestational stage. These results suggest that scrapie trans-
mission through uterine-placental tissues may be reduced or
eliminated if the infected ewes are not pregnant or conceive
conceptuses with a resistant genotype.
Materials and Methods
Animals, Tissue Collection, and Processing. All ewes (n  61) in this
study were either uninfected or naturally infected 171QQ Suf-
folk or Suffolk  Hampshire sheep. The scrapie status of the
fetal, young, and adult ewes was determined before euthanasia,
at necropsy, or at lambing by immunohistochemistry (22). Of 32
peripheral lymphoid tissue [live animal test of the third-eyelid
lymphoid tissue (22)] PrPSc-positive ewes used in this study, 19
ewes exhibited clinical symptoms including pruritis, wool loss,
weight loss, andor ataxia. Eleven scrapie-infected ewes were
mated to a 171QQ ram, 6 scrapie-infected ewes were mated to
a 171RR ram, 25 uninfected ewes were mated to a 171QQ ram,
and 15 scrapie-infected and 4 uninfected ewes were not mated.
Infected ewes pregnant with 171QQ conceptuses were eutha-
nized either at early (days 40–60; n  8), mid- (days 80–100; n 
1), or term (Days 140–150; n  2) pregnancy. All infected ewes
pregnant with 171QR conceptuses were euthanized at term
pregnancy, except for one that was euthanized at mid-pregnancy.
All uninfected pregnant ewes were euthanized between days 40
and 140 of pregnancy. The uninfected ewes had no reported
exposure to scrapie, and PrPSc was not detected in brain or tonsil
by Western blotting or immunohistochemistry. The genotypes of
fetuseslambs and placentae were determined by sequencing of
the prion gene.
Brainstem, tonsil, placentomes, interplacentomal endometri-
Abbreviations: PrP, prion protein; PrPC, cellular PrP; PrPSc, scrapie PrP; 171QQ, -RR, or -QR,
homozygous for glutamine or arginine, or heterozygous for glutamine and arginine at
codon 171 of the PrP gene; PK, proteinase K.
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al-chorioallantois, ovary, oviduct, mammary gland, and bladder
collected at euthanasia were fixed in 10% buffered formalin and
processed for immunohistochemistry as described previously
(22). Maternal brainstem, tonsil, dissected uterine caruncular
(caruncles) and interplacentomal (intercaruncular) endometria,
placental cotyledonary (cotyledons) and interplacentomal (in-
tercotyledonary) chorioallantois, ovary, oviduct, mammary
gland, and bladder of pregnant ewes, and fetal brain, kidney and
bladder at different stages of pregnancy were collected and
snap-frozen in liquid nitrogen and stored at 80°C until use. For
each fetal unit, 2–3 placentomes and dissected caruncles and
cotyledons from 3–6 placentomes were collected from each of
the three areas occupied by the head, mid-body and tail of a
fetus. A schematic illustration of the ovine placentome is shown
in Fig. 1. Animal Care and Use Protocols were approved by the
Institutional Animal Care and Use Committee of Washington
State University.
Tissue Homogenate Preparation and Western Blot Analysis. Tissue
homogenates were prepared with (for PrPSc detection) or with-
out (for PrPC andor PrPSc detection) the use of 10% sarkosyl
and ultracentrifugation as described (9). Briefly, tissue was
homogenized and incubated for 30 min at 37°C in 10 mM
TrisHCl (pH 7.5), 5 mM MgCl, and DNase (200 gg wet
tissue), followed by 30 min incubation at room temperature in
sarkosyl solution (10 mM TrisHCl, pH 7.520% sarkosyl). The
homogenate was centrifuged at 6,000  g for 10 min, and the
resultant supernatant was centrifuged at 348,000  g for 50 min
at room temperature. The pellet was dissolved in 10 mM
TrisHCl (pH7.5) and treated with or without PK (20 gml) at
37°C for 30 min. The PK-treated mixture was centrifuged at
279,000  g for 30 min. The pellet was resuspended in 10 mM
TrisHCl and boiled in sample buffer before Western blotting.
Western blot procedure was performed (9, 23). Briefly, tissue
homogenates were analyzed by 12% SDSPAGE (Invitrogen),
followed by transfer to poly(vinylidene difluoride) (PVDF)
membranes (Amersham Pharmacia) before detection by anti-
prion mAb F9997.6.1 (22) and goat anti-mouse IgG-
horseradish peroxidase (HRPO) (Southern Biotechnology As-
sociates), and developed with a chemiluminescence substrate
(Amersham Pharmacia).
Immunohistochemistry. Immunohistochemistry was performed as
previously described (22). Briefly, tissues were fixed in 10%
neutral buffered formalin for 2–7 days, treated with 95% formic
acid for 1 h, rinsed with water, and fixed for an additional 24 h
before embedding in paraffin. Tissue sections placed on glass
slides were deparaffinized, hydrated, and autoclaved in Target
Retrieval Solution (pH 6; DAKO) at 121°C for 30 min. Slides
were stained by using an automated stainer (Ventana Medical
Systems, Tucson, AZ). Anti-prion mAbs F9997.6.1 and F89
160.1.5 (22, 23) were used as primary reagents, followed by the
application of a biotinylated secondary antibody, streptavidin-
alkaline phosphate complex and alkaline phosphatase substrate
(Ventana Medical Systems). Controls included isotype-matched
irrelevant IgG and blocking of the mAbs with synthetic peptides
to which the mAbs were raised. All slides were counterstained
with hematoxylin. Photomicrographs were taken with a micro-
scope equipped with a digital camera.
The medial cross section of a placentome was divided into
three zones in parallel to the myometrium (Fig. 1). Zone A is
proximal to the myometrium and composed of endometrial-
chorioallantoic interdigitation at the base of the placentome;
zone C is composed of the distal portion of the interdigitating
tissue, which contains the arcade systems or hematomata; and
zone B is the intermediate area. All stained PrPSc plaques within
each zone of the entire medial sections of placentomes of early,
mid-, and term pregnant scrapie-infected ewes were enumerated
by using a bright field microscope.
Statistical Analysis. Percent total PrPSc plaques from different
zones of placentomes of infected ewes with 171QQ conceptuses
during early and term pregnancies were analyzed by one-way
ANOVA with a Student-Newman Keuls multiple comparisons
test. Probability values of P  0.05 were used.
Results
Detection Of PrPSc in Placentomes Consisting of 171QQ Uterine Ca-
runcular Endometrium and 171QQ Placental Cotyledonary Cho-
rioallantois from Scrapie-Infected Ewes. Scrapie-infected sheep
were defined by PrPSc accumulation in brain andor lymphoid
tissue by using an immunohistochemistry assay (22). Uterine and
placental tissues collected during various stages of pregnancy
were assayed for PrPSc by immunohistochemistry. PrPSc was
detected in placentomes consisting of 171QQ uterine (caruncu-
lar endometrium) and 171QQ placental (cotyledonary cho-
rioallantois) tissues collected from 10 of 11 of the pregnant (day
40–term post mating) scrapie-infected ewes (Fig. 2 A and D).
PrPSc was not detected in 171QQ placentomes of 1 of 11
pregnant scrapie infected ewes (Table 1). This placentomal
PrPSc-negative sheep was bred before arriving at this U.S.
Department of AgricultureAgricultural Research Service sta-
tion; therefore, the gestational stage at euthanasia was unknown.
However, we determined that this sheep was at an early stage of
pregnancy when euthanized (data not shown). PrPSc was not
detected in maternal intercaruncular endometrium, intercoty-
ledonary chorioallantois, amniotic membrane, myometrium,
ovary, oviduct, bladder, or mammary gland, fetal bladder,
kidney, and brain of these pregnant scrapie-infected ewes (data
not shown), or 171QQ placentomes of uninfected ewes (n  25;
Table 1). Interestingly, no PrPSc was detected in placentomes of
Fig. 1. A schematic illustration of a medial cross section of an ovine placen-
tome. The placentome is a natural chimera, consisting of interdigitating
uterine (placentomal or caruncular endometrium) and placental (placentomal
or cotyledonary chorioallantois) tissues. The medial cross section of a placen-
tome is divided into three zones: zones A, B, and C. Zone A contains maternal
endometrial crypts and the distal ends of the cotyledonary villous tree and is
located closest to the endometrial stalk and myometrium, zone B is the
intermediate area, and zone C is the distal (relative to myometrium) portion
of the placentome containing the distal ends of endometrial septae and the
chorionic plate. Zone C is typically characterized by structures known as arcade
system or hematomata. The placentomal endometrium consists of the uterine
superficial epithelium and associated stroma, but no glands. Interplacentomal
endometrium consists of loosely attached intercotyledonary chorioallantois
and intercaruncular endometrium, which is rich in glands. Pla. villus, placental
villus; m-septum, maternal endometrial septum; m-crypt, maternal crypt; end.
stalk, endometrial stalk.









171QQ uterine and 171QR placental tissues from scrapie-
infected ewes (n  6; Table 1).
All ewes studied were between 2 and 5 years old and had PrPSc
in the brain and lymphoid tissue. Eight of these 18 ewes exhibited
clinical signs of scrapie infection at euthanasia. However, no
correlation was found between the presence of PrPSc in placen-
tomes and age, stage of pregnancy, or clinical status of the dams
(Table 1).
We confirmed the presence of PrPSc by Western blotting in
171QQ placentomal endometrium and chorioallantois collected
at term pregnancy (Fig. 3C, lanes 4 and 6). PrPSc was not
detected in uterine or placental tissues of uninfected ewes (Fig.
3A, lanes 5 and 8) or in scrapie-infected ewes pregnant with
171QR conceptuses (Fig. 3D, lanes 4 and 6). PrPC in brain,
uterine, and placental tissues of uninfected sheep (Fig. 3A, lanes
1, 3, and 6) and PrPSc in brain of scrapie-infected sheep (Fig. 3
B–D, lane 2) were readily detectable by Western blotting using
direct tissue homogenates without further enrichment (9). How-
ever, PrPSc was not consistently detectable in the uterine and
placental tissues unless prepared by ultracentrifugation in the
presence of sarkosyl (9, 17). Furthermore, PrPSc was not detect-
able by Western blotting in uterine and placental tissues of early
pregnant (day 40–60 post mating) scrapie-infected ewes (data
not shown). Therefore, uterine and placental tissues collected
from term pregnant ewes were prepared for Western blotting by
ultracentrifugation in the presence of sarkosyl.
PrPSc Was Not Detected in Reproductive Tissues of Non-Pregnant,
171QQ, Scrapie-Infected Ewes. PrPSc accumulation in the repro-
ductive tissues in 15 scrapie-infected and 4 uninfected non-
pregnant 171QQ ewes was determined (Table 1). All scrapie-
infected ewes had PrPSc accumulation in brain and lymphoid
tissue and some (11 of 15) exhibited clinical signs of scrapie
(Table 1). No PrPSc was detected in brain or lymphoid tissues of
uninfected non-pregnant ewes (data not shown). Homogenates
of tissues from infected ewes were prepared with or without
ultracentrifugation in the presence of sarkosyl. PrPSc was not
detected by either Western blotting (Fig. 3B, lanes 5 and 8) or
immunohistochemistry (data not shown) in brain, maternal
caruncular endometrium and myometrium, intercaruncular en-
dometrium, ovary, oviduct, bladder, or mammary gland of
non-pregnant scrapie-infected ewes, nor in any of the reproduc-
tive tissues of non-pregnant uninfected ewes (data not shown).
Distribution of PrPSc Plaques in 171QQ Placentomes of Scrapie-
Infected Ewes Is Associated with Stage of Pregnancy. Ten scrapie-
infected ewes tested positive for PrPSc in placentomes collected
between day 40 post mating and term (Table 1). PrPSc was
localized as plaques in placentomes of these ewes by immuno-
histochemistry (Fig. 2 A and D), and the size and location of
PrPSc plaques in these placentomes varied depending on gesta-
tional stage (Table 2). PrPSc plaques were seen in placentomal
areas where both placental villi and endometrial septae were
present, but not in placentomal regions with endometrial tissue
alone (Fig. 2A). PrPSc plaques in early pregnant placentomes
(days 40–60 post mating; Fig. 2 A) were small relative to the
plaques in term placentomes (Fig. 2D) and were located in the
area of maternal endometrial crypts of zone A (Fig. 4; Table 2).
PrPSc staining in term pregnant placentomes was a mixture of
small and large plaques located primarily in zone C near the
chorionic plate of the placentome (Table 2; Fig. 4). The PrPSc
plaques in zone C (75% of total plaques) were more abundant
(P  0.001) than those in zone B (16% of total plaques) andor
zone A (7% of total plaques) of term pregnant placentomes of
scrapie-infected ewes (Fig. 4). Zone B of the placentome had
primarily small PrPSc plaques (data not shown).
Cellular Localization of PrPSc in Uterine Caruncular Endometrial Epi-
thelium and Placental Cotyledonary Chorioallantoic Trophoblast of
171QQ Placentomes. Cellular localization of PrPSc in placentomes
of scrapie-infected ewes is shown in Fig. 2. Both mAbs used in
the present study bound with identical patterns; the results
obtained by using mAb F9997.6.1 are shown. As shown in Fig.
2 B and C for placentomes collected from early pregnant
scrapie-infected ewes, PrPSc staining was primarily associated
with uterine endometrial epithelium, trophoblast cells, and
multinucleate cells in zone A of the maternal endometrial crypts.
Very little mAb binding was found in zones B and C of
placentomes from early pregnant scrapie-infected ewes. PrPSc
was not detected in the stroma or blood vessels (data not shown).
Fig. 2. Immunohistochemical analysis of PrPSc in placentomes of scrapie-
infected ewes. The presence of pink staining is indicative of the presence of
PrPSc. TROEND, trophoblast-endometrium interdigitation; TRO, trophoblast;
END, endometrium; m-crypt, maternal crypt; MNC, multinucleated cells; RBC,
maternal erythrocytes; hemat, hematomata; D-END, degenerating endome-
trium; ALL, allantoic cavity; BNC, binucleate cells; SYN, endometrial syncytium.
(A) PrPSc plaques in the 171QQ placentome of a scrapie-infected ewe at day 40
of pregnancy (100). PrPSc was seen only in endometrialplacental interdig-
itation, not in endometrium alone. The yellow line represents the border
between maternal endometrium and trophoblastendometrium interdigita-
tion at the fetal–maternal interface at the bottom of the maternal crypt. (B)
PrPSc in cells in the maternal crypt (m-crypt) in the 171QQ placentome of an
early pregnant scrapie-infected ewe (200). (C) PrPSc in a multinucleated cell
(MNC) located in the maternal crypt in the 171QQ placentome of an early
pregnant scrapie-infected ewe (400). (D) A PrPSc plaque in zone C of a 171QQ
placentome of a term pregnant scrapie-infected ewe (100). The yellow circle
defines the PrPSc plaque. (E) PrPSc in maternal endometrial epithelial cells in
the 171QQ placentome of a term pregnant scrapie-infected ewe (400). (F)
PrPSc in both endometrial epithelial cells (END) and trophoblast cells (TRO) in
the 171QQ placentome of a term pregnant scrapie-infected ewe (200). (G)
PrPSc in placental trophoblast cells (TRO) located along the hematomata
(hemat) (400). Phagocytosed RBCs (RBC and arrow) were apparent in the
placental trophoblast cells. The yellow line defines part of the hematomata
containing maternal blood (RBC) and degenerating endometrium (D-END).
(H) A placentomal cross section near the endometrial stalk stained with an
isotype-matched mAb (400).
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No particular uterine or placental structures were associated
with this distribution pattern.
In term pregnant scrapie-infected ewes, PrPSc was clearly
detected in single cell layers of the endometrial epithelium and
placental trophoblast cells (Fig. 2 E, F, and G), as well as in the
uterine syncytium (data not shown), a structure formed by fusion
of endometrial epithelial cells during normal pregnancy (24).
Although staining for PrPSc was present in both uterine epithe-
lium and trophoblast cells throughout the placentome, there was
a tendency toward increased accumulation of PrPSc in tropho-
blast cells in zone C rather than zones A and B in scrapie-infected
ewes. In addition, abundant PrPSc was detected in chorionic
trophoblast cells around the hematomata, which contains ma-
ternal blood as a result of degeneration of the distal ends of the
maternal endometrial septae in this region (refs. 24 and 25;
Fig. 2G).
PrPSc was not detected by immunohistochemistry in endome-
trial glands, which were abundant in the interplacentomal region
but absent in the placentomal region, nor in intercaruncular
endometrium, myometrium, or the interplacentomal endome-
trial-chorioallantois of scrapie-infected ewes (data not shown).
PrPSc was not found in replicate tissue sections when isotype-
matched irrelevant IgG mAbs or mAbs absorbed with peptide-
antigen were used as the primary antibody (Fig. 2H).
Discussion
Susceptibility to scrapie in Suffolk and Suffolk cross-bred sheep
is determined primarily by codon 171 of the PrP gene. Sheep with
a 171QQ genotype are susceptible to scrapie, and those with a
171QR or 171RR genotype are resistant to scrapie (11, 13), with
a few exceptions (26, 27). The present study investigated the
effects of offspring genotype and pregnancy on PrPSc accumu-
lation at the fetal–maternal interface of scrapie-infected sheep
and possible transmission between tissues of different genotypes
by using the ovine placentome as a natural chimeric model.
PrPSc was present at the fetal-maternal interface, endome-
trium, and the apposing placental chorioallantois in 171QQ
placentomes of most (1011) infected ewes with PrPSc in the
brain and lymphoid tissue. PrPSc was not detected in the uterine
tissues of non-pregnant infected ewes, nor in the uterine or
placental tissues of infected ewes carrying 171QR fetuses. PrPSc
was not detected in 171QQ placentomes from one scrapie-
infected ewe. Based on placentomal morphology, this sheep was
considered at an early stage of pregnancy when euthanized,
suggesting that detectable levels of PrPSc had not yet accumu-
lated in placentomes. The results of this study suggest that the
accumulation of PrPSc in the uterus is pregnancy dependent and
that PrPSc accumulation in the placentome requires the presence
of a 171QQ conceptus. These observations support earlier
reports that transmission is related to lambing (9, 14, 17) and
suggest that transmission may be reduced or eliminated if









PrPSc accumulation in tissues
Dam Fetus Bra  lym Plact Np-ute
Uninfected QQ QQ 25 025 Px 025 025 —
QQ — 4 04 NP 04 — 04
Infected QQ QQ 11 611 Px 1111 1011 —
QQ QR 6 26 Px 66 06 —
QQ — 15 1115 NP 1515 — 015
Uninfected, Animals that had no reported exposure to scrapie and disease status confirmed by Western blotting and immunohistochemistry of postmortem
brain and lymphoid tissues; Infected, animals that either exhibited clinical signs of scrapie or had detectable PrPSc in the lymphoid tissue (based on a live animal
third eyelid test) prior to experiment. Genotype, Allelic coding amino acid variation at codon 171 of the prion gene; QQ, homozygous for glutamine; QR,
heterozygous for glutamine and arginine; RR, homozygous for arginine. Clinical disease, The number of sheep with clinical scrapie vs. total number of infected
sheep used (preclinical sheep had PrPSc in brain andor lymphoid tissues but no clinical signs, which include rubbing and wool loss, progressive weight loss, and
ataxia). Pregnancy status, Px, pregnant; NP, non-pregnant. Bra  lym, PrPSc detected in postmortem brain and lymphoid tissue; plact, placentome; np-ute,
non-pregnant uterus.
Fig. 3. Western blot of PrPSc in tissue homogenates of brainstem, uterine
caruncular endometrium, and placental cotyledonary chorioallantois of preg-
nant and non-pregnant ewes with or without scrapie. Protein from 0.5 mg
brainstem or 30 mg endometrium, chorioallantois, and other tissues was loaded
in each lane. PK (20 gml) treatment at 37°C for 30 min of each tissue homog-
enate is indicated at the bottom of each panel (). (A) Western blot of tissue
homogenates prepared from brainstem (lanes 1 and 2), uterine caruncular en-
dometrium (lanes 3–5), and cotyledonary chorioallantois (lanes 6–8) of an unin-
fected ewe (171QQ) pregnant (day 145 post mating) with a 171QQ conceptus.
Samples in lanes 4, 5, 7, and 8 were prepared with sarkosyl and ultracentrifuga-
tion. Tissue homogenates were with (lanes 2, 5, and 8) or without (lanes 1, 3, 4,
6, and 7) PK treatment. (B) Western blot of tissue homogenates of brainstem
(lanes 1 and 2), endometrium (lanes 3–5), and myometrium (lanes 6–8) of a
non-pregnant scrapie-infected ewe (171QQ). Samples in lanes 4 and 5 and in
lanes 7 and 8 were prepared with sarkosyl and ultracentrifugation. Tissue ho-
mogenates were with (lanes 2, 5, and 8) or without (lanes 1, 3, 4, 6, and 7) PK
treatment. (C) Western blot of tissue homogenates prepared from brainstem,
caruncular endometrium, and cotyledonary chorioallantois of a scrapie-infected
ewe (177QQ) pregnant with a 171QQ conceptus. Lanes 1 and 2, brainstem
prepared without sarkosyl and ultracentrifugation; lanes 3 and 4, uterine carun-
cular endometrium prepared with sarkosyl and ultracentrifugation; and lanes 5
and 6, placental cotyledonary chorioallantois prepared with sarkosyl and ultra-
centrifugation. Tissue homogenates were with (lanes 2, 4, and 6) or without
(lanes1,3,and5)PKtreatment. (D)Westernblotof tissuehomogenatesprepared
from brainstem, caruncular endometrium, and cotyledonary chorioallantois of a
scrapie-infected ewe (177QQ) pregnant with a 171QR conceptus. Lanes 1 and 2
(brainstem), prepared without sarkosyl and ultracentrifugation; lanes 3 and 4
(uterine caruncular endometrium), prepared with sarkosyl and ultracentrifuga-
tion; and lanes 5 and 6, placental cotyledonary chorioallantois prepared with
sarkosyl and ultracentrifugation. Tissue homogenates were with (lanes 2, 4, and
6) or without (lanes 1, 3, and 5) PK treatment.









infected ewes are not pregnant or conceive offspring with a
scrapie-resistant genotype. The mechanisms by which pregnancy
affects PrPSc deposition in the uterus of genetically susceptible
sheep are not known. We showed previously that PrPC expres-
sion is up-regulated in pregnant caruncular endometrium where
intimate contact of placental and uterine tissues occur, suggest-
ing that molecules expressed by the cotyledonary trophoblast
cells, uterine–placental cell–cell contact in the placentome,
andor the presence of pregnancy-associated hormones are
important for PrPC expression and PrPSc accumulation in the
caruncular endometrium during pregnancy (9). It is intriguing
that PrPSc was absent from the uterine tissue of infected ewes
pregnant with 171QR conceptuses. This ‘‘blockage’’ of in vivo
PrPSc formation in the presence of placental 171QR and pla-
centalmaternal 171QQ PrP may be similar to the interference
of PrPSc formation by heterologous PrP molecules shown in vitro
(28, 29). One may speculate that placental 171QR PrP expressed
by trophoblast cells may interact with uterine PrPSc through
cell–cell contact and inhibit the conversion process. In vitro and
in vivo studies to examine the role of cell-free and cell-associated
trophoblast-derived factors in PrPSc propagation in uterine cells
and the systemic effects of pregnancy in the absence of cell-to-
cell contact with trophoblast will provide additional information
on this critical transmission step. The efficient conversion of PrP
in the placentome (detectable during 40–145 days post mating)
compared with the lymphoid tissues (10–14 months after expo-
sure during the perinatal period) or the brain (2 to 3 years after
exposure) (15) provides a useful model system for examining PrP
conversion under natural conditions.
This study demonstrated that PrPSc was localized to the ovine
uterine and placental epithelial cells. Because no antibodies to
specific markers of these epithelial cells were available, the
maternal or fetalplacental origin of these cells at the interface
during early pregnancy was estimated by location and morphol-
ogy under light microscopy. PrPSc was detected in the uterine
cells, mononuclear trophoblast cells, and the multinucleated
cells formed by fusion between uterine epithelial and placental
trophoblast cells. However, PrPSc appeared more abundant in
the endometrial epithelial cells than in trophoblast cells in zones
A and B of the placentome during early and mid pregnancy. The
binucleate cells that originate from the trophoblast cells and
invade massively into the endometrium were generally not
associated with PrPSc staining (30). PrPSc was clearly present in
both uterine and trophoblast cells in zone C of the prepartum
placentome particularly. Abundant PrPSc was present in tropho-
blast cells in zone C near the allantoic cavity. The translocation
of the PrPSc from primarily uterine epithelial cells in zone A
during early pregnancy to the placental trophoblast cells in zone
C at term pregnancy may represent a critical step in the
transmission of the scrapie agent from the maternal tissue to
placental tissue.
Interestingly, placentomal PrPSc was distributed in discrete
plaques. The ovine placentome appears to be a homogenous
interdigitation between the endometrial septae and chorioallan-
toic villi, and the PrPSc plaques in placentomes were not asso-
ciated with any identifiable landmark structures. However, the
spatial distribution pattern of the PrPSc plaques was highly
associated with stage of pregnancy. The transition from smaller
PrPSc plaques in zone A near the endometrial stalk during early
pregnancy to relatively larger PrPSc plaques in zone C near the
chorionic plate at term pregnancy may represent a temporal
process of PrPSc accumulation and maternal-placental PrPSc
transmission. The mechanism of such a transient change in
plaque size and location are currently unknown. The fact that
placentomal PrPSc plaques of early pregnancy were formed
primarily in the maternal endometrial crypts containing the top
of the chorionic villi, but not in the endometrium without the
chorionic villous tree, supports the concept that the presence of
placental tissue is critical for PrPSc accumulation. At term
pregnancy, PrPSc plaques were located in the vicinity of the
structure known as hematomata in zone C of the placentome.
The formation of ovine placentomes is initiated at the time of
attachment of uterine caruncles to placental cotyledons and is
gradually completed by mid-pregnancy through uterine-
placental interdigitation when the distal ends of the endometrial
septae and chorionic villi reach the chorionic plate and endo-
metrial stalk, respectively (Fig. 1). During the second half of
pregnancy in sheep, the distal ends of the endometrial septae
degenerate through an unknown mechanism, and maternal
blood leaks through the broken blood vessels into the space
surrounded by the intact trophoblast cells of the chorionic villi,
leading to the formation of hematomata or the arcade systems
in the placentome (24). By term pregnancy, particularly imme-
diately before lambing, massive bleeding is seen in all placen-
tomes, appearing as a dark brown color in the cotyledonary
chorioallantois. Thus, hematomata contains maternal blood and
degenerated and degenerating endometrial tissue. The tropho-
blast cells of the hematomata are highly phagocytic, and are
thought to play an important role in nonspecific uptake of
Table 2. Correlation between stage of pregnancy and spatial distribution of PrPSc in placentomes of pregnant scrapie-infected ewes
PrPSc
Stage of pregnancy
Early (n  7) Mid (n  1) Term (n  2)
Pattern of PrPSc distribution Numerous small plaques in
multinucleate cells
Mostly small plaques and few large
plaques
Primarily large plaques spanning several
villi
Location of PrPSc plaque Maternal crypts of zone A Primarily maternal crypt of zone A and
some in zone B
Primarily zone C
PrPSc was defined by immunohistochemistry. Early pregnancy, days 40–60 post mating; mid-pregnancy, days 80–100 post mating; term pregnancy, days
140–150 post mating.
Fig. 4. Distribution of PrPSc plaques in zones A, B, and C of the placentome
of ewes infected with scrapie during early (n  7) and term (n  2) stages of
pregnancy. The total number of PrPSc plaques in medial sections of two
separate placentomes of each scrapie-infected ewe was counted microscop-
ically. The results are expressed as the percentage of total PrPSc plaques.
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maternal endometrial secretions, cellular debris, and maternal
blood, especially red blood cells, as a source for nutrients of the
fetus (24, 25, 31). Indeed, the phagocytosis of maternal red blood
cells by placental trophoblast cells was seen in both normal and
scrapie-infected animals. Because phagocytosis at the fetal–
maternal interface is a nonspecific process, this may be one way
for the placental trophoblast cells to acquire PrPSc from the
degenerating endometrial cells in the hematomata.
This study demonstrated that offspring genotype and preg-
nancy are determining factors for PrPSc accumulation at the
fetal–maternal interface of scrapie-infected ewes. The charac-
teristic spatial distribution of PrPSc at the interface during
different stages of pregnancy may indicate a temporal course of
maternal–placental transmission of scrapie. This study presented
evidence that scrapie may not be transmissible between infected
genetically susceptible uterine tissue and placental tissue with a
resistant genotype using the natural chimeric model, the ovine
placentome. The results of this study provide useful information
for further understanding of scrapie transmission in species with
extraneural accumulation of PrPSc. The nature of the PrPSc
converting process in the pregnant uterus, the possible inhibitory
effect of placental 171QR PrP molecules on PrPSc formation in
the uterus, the identity of the pregnancy-related cells or mole-
cules that allow the rapid accumulation of PrPSc in the placen-
tome, and the source of PrPSc in phagocytic trophoblast cells
remain to be determined. Additional in vivo studies with sheep
at different stages of gestation resulting from genetically con-
trolled mating as well as in vitro studies with uterine epithelial
and trophoblast cell lines will provide a better understanding of
cellular and molecular basis for transmission of scrapie, a
prototype transmissible spongiform encephalopathy.
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